- 24 November, 2024
Clover Health stock price forecast ahead of Q1 earnings
The Clover Health (NASDAQ: CLOV) stock price is hovering near its lowest level on record ahead of the company’s upcoming quarterly results. The shares are
Nasdaq 100 forms death cross as the fear and greed index slips
The Nasdaq 100 index has been in a spectacular meltdown as investors worry about the rising interest rates and slowing growth. The index is trading
Should I buy Arista Networks shares after a strong Q1 performance?
Arista Networks, Inc. (NYSE: ANET) posted first-quarter results that topped expectations, and Jim Suva, an analyst from Citigroup, assigned a buy rating on Arista shares.
Hold Cigna stock as it eyes a breakout after boosted outlook
Health insurer Cigna Corporation (NYSE:CI) closed up 5.88% on Friday, making it among the top S&P gainers. The gains came at the back of an
Bullish BP approaches a key zone and you should keep watch
In just five days, British Petroleum Plc. (LON:BP) has returned over 11%. The returns compare to a 16% return year-to-date. The growing popularity of firms
Sanctuary Wealth CIO: these two ‘boring’ stocks are now a ‘buy’
Invezz does not provide financial advice. Our aim is to simplify information about investing, enabling each user to make educated decisions with their money and
MaxLinear announces acquiring Silicon Motion
MaxLinear, Inc. (NASDAQ: MXL), a provider of RF (radio frequency, mixed-signal integrated and analog circuits for broadband, infrastructure and connectivity markets, has executed a definitive purchase
Why iRhythm Technologies jumped 20%
iRhythm Technologies Inc. (NASDAQ: IRTC) was up 20% after the digital healthcare solutions firm focusing on cardiac care advancement announced its financial results for the
U.S. economy added 428K jobs in April: what does it mean for investors?
Bureau of Labour Statistics on Friday said the U.S. economy added 428,000 jobs in April. The number topped economists’ forecast by 37,000. What does it
Here is why Intercept is up 30%
Intercept Pharmaceuticals Inc. (NASDAQ: ICPT) shares are up 30% after announcing an agreement to sell some of its foreign subsidiaries plus rights to its international